3:190290361-190412138 (GRCh38) | |||||||
Official synonyms | |||||||
UniProt | |||||||
InterPro domains | |||||||
PFAM | |||||||
WikiPathways | |||||||
Reactome pathways | |||||||
HPO |
|
||||||
Orphanet | |||||||
OMIM gene info |
CLAUDIN 16; CLDN16
603959
CLDN16 is selectively expressed at tight junctions of renal epithelial cells of the thick ascending limb of the Henle loop, where it plays a central role in the reabsorption of divalent cations (Kausalya et al., 2006). CLONING The paracellin-1 gene encodes a protein of 305 amino acids with 4 transmembrane domains and intracellular N and C termini (Simon et al., 1999). The PCLN1 protein shows sequence and structural similarity to members of the claudin family (see 603718), with 10 to 18% amino acid identity with individual claudins. The highest homology between PCLN1 and the claudins is in a segment of the first extracellular domain that is thought to bridge the intracellular space. PCLN1 has a consensus threonine-X-valine PDZ-binding domain at the C terminus. Unlike the other claudins, which have an amino terminus of only 6 to 7 amino acids, PCLN1 encodes a cytoplasmic amino terminus of 73 amino acids. This segment is highly hydrophilic with a net positive charge. Northern blot analysis revealed that PCLN1 is expressed as a 3.5-kb transcript that is found only in kidney. Expression studies of PCLN1 indicated that PCLN1 mRNA is detectable only in the thick ascending limb of Henle and in the distal convoluted tubule. Confocal microscopy using antibodies to both PCLN1 and occludin (602876) demonstrated that both are found to colocalize, indicating that PCLN1 is a component of the tight junction. GENE STRUCTURE Simon et al. (1999) determined that the PCLN1 gene consists of 5 exons, each flanked by canonic splice donor and acceptor sequences. GENE FUNCTION Using a library of endoribonuclease-prepared short interfering RNAs (esiRNAs), Kittler et al. (2004) identified 37 genes required for cell division, one of which was CLDN16. These 37 genes included several splicing factors for which knockdown generates mitotic spindle defects. In addition, a putative nuclear-export terminator was found to speed up cell proliferation and mitotic progression after knockdown. MOLECULAR GENETICS Epithelia permit selective and regulated flux from apical to basolateral surfaces by transcellular passage through cells or paracellular flux between cells. Tight junctions constitute the barrier to paracellular conductance. Renal magnesium ion resorption occurs predominantly through a paracellular conductance in the thick ascending limb of Henle. Simon et al. (1999) used linkage analysis and positional cloning to identify the paracellin-1 gene as mutated in families with primary hypomagnesemia (248250). Using 12 kindreds with typical recessive hypomagnesemia and whole genome analysis, Simon et al. (1999) demonstrated linkage to a segment of chromosome 3q with a lod score of 6.8. Further analysis localized the trait locus to a 1-cM interval flanked by loci 539-5 and D3S1288. Simon et al. (1999) identified 10 different mutations in the PCLN1 gene that altered the protein in 10 kindreds with primary hypomagnesemia. Patients were homozygous for mutations in 8 kindreds and compound heterozygous in 2 outbred kindreds. Mutations included premature termination codons, splice site mutations, and missense mutations. Simon et al. (1999) concluded that their results identified PCLN1 as a renal tight junction protein that when mutated causes massive renal magnesium wasting with hypomagnesemia and hypercalciuria, resulting in nephrocalcinosis and renal failure. Simon et al. (1999) inferred that these mutations cause loss of normal PCLN1 function and that no other genes are redundant in function to PCLN1. Weber et al. (2000) performed linkage analysis in 8 families with hypomagnesemia, including 3 with consanguineous marriages. They found linkage to microsatellite markers on 3q27 with a maximum 2-point lod score of 5.208 for D3S3530 without evidence for genetic heterogeneity. Haplotype analysis revealed crucial recombination events reducing the critical interval to 6.6 cM. Mutation analysis of the PCLN1 gene in their 8 families revealed 8 different mutations in the PCLN1 gene, including 5 novel mutations. In 7 of 13 mutant alleles, they detected a leu151 substitution without evidence for a founder effect: leu151 to phe (603959.0010), leu151 to trp (603959.0011), and leu151 to pro (603959.0014). Leu151 is a residue of the first extracellular loop of paracellin-1, the part of the protein expected to bridge the intercellular space and to be important for paracellular conductance. The study pointed to the predominant role of paracellin in the paracellular reabsorption of divalent cations in the thick ascending limb of the loop of Henle. Weber et al. (2001) suggested that individuals heterozygous for CLDN16 mutations may be at increased risk of developing renal stone disease (nephrolithiasis). Muller et al. (2003) screened a cohort of 11 families with idiopathic hypercalciuria and identified a novel homozygous mutation in the CLDN16 gene (T233R; 603959.0015) in 2 families. In contrast to classic symptoms of familial hypomagenesemia with hypercalciuria and nephrocalcinosis, patients displayed serious but self-limiting childhood hypercalciuria with reserved glomerular filtration rate. They showed that the mutation results in an activation of a PDZ-domain binding motif, thereby disabling the association of the tight junction scaffolding protein ZO1 (601009) with CLDN16. In contrast to wildtype CLDN16, the mutant no longer localized to tight junctions in kidney epithelial cells but instead accumulated in lysosomes. Thus, mutations at different intragenic sites in the CLDN16 gene may lead to particular clinical phenotypes with a distinct prognosis. Mutations in CLDN16 that affect interaction with ZO1 lead to lysosomal mistargeting, providing insight into the molecular mechanism of a disease-associated mutation in the CLDN16 gene. By transfecting mutant CLDN16 cDNAs into human and canine polarized epithelial cells, Kausalya et al. (2006) found that 9 of 21 disease-associated mutant CLDN16 proteins were retained in the endoplasmic reticulum, where they underwent proteasomal degradation. Of the others, 3 accumulated in the Golgi complex, 2 were delivered to lysosomes, and 7 localized to tight junctions. One of the 2 mutants delivered to lysosomes was exposed on the cell surface prior to internalization. Of the mutants delivered to the cell surface, 4 were defective in paracellular Mg(2+) transport. Pharmacologic chaperones rescued surface expression of several retained CLDN16 mutants. ANIMAL MODEL Ohba et al. (2000) showed that hereditary renal tubular dysplasia, an autosomal recessive disease of Japanese black cattle, is associated with deletion of a bovine chromosome 1 microsatellite marker. This region includes sequences encoding bovine Cldn16. The authors suggested that the cattle disease could be a model for human renal hypomagnesemia. |
||||||
OMIM |
HYPOMAGNESEMIA 3, RENAL; HOMG3
248250
INHERITANCE: Autosomal recessive GROWTH: [Other]; Failure to thrive HEAD AND NECK: [Eyes]; Strabismus; Nystagmus; Hyperopia; Myopia; Astigmatism ABDOMEN: [Gastrointestinal]; Abdominal pain; Feeding problems GENITOURINARY: [Kidneys]; Polyuria; Nephrocalcinosis; Progressive renal insufficiency; Renal failure; Nephrolithiasis; Renal magnesium wasting; Renal calcium wasting; [Bladder]; Recurrent urinary tract infections MUSCLE, SOFT TISSUE: Tetany NEUROLOGIC: [Central nervous system]; Seizures METABOLIC FEATURES: Polydipsia; Incomplete distal renal tubular acidosis LABORATORY ABNORMALITIES: Hypomagnesemia; Normal serum calcium; Elevated parathyroid hormone; Hyperuricemia; Hypermagnesiuria; Hypercalciuria; Hypocitraturia; Hematuria; Abacterial leukocyturia MISCELLANEOUS: Onset in early childhood; Presenting symptoms - recurrent UTI, polyuria/polydipsia, hematuria, and abacterial leukocyturia; Hypercalciuria and/or nephrolithiasis occurs in heterozygotes MOLECULAR BASIS: Caused by mutation in the claudin 16 gene (CLDN16, 603959.0001) A number sign (#) is used with this entry because the disorder is caused by mutation in the claudin-16 gene on chromosome 3 (CLDN16; 603959). A similar disorder with renal magnesium wasting, renal failure, and nephrocalcinosis (248190) is caused by mutations in another tight-junction gene, CLDN19 (610036), and is distinguished by the association of severe ocular involvement. See also Gitelman syndrome (263800), a disorder of combined potassium and magnesium depletion. For a discussion of genetic heterogeneity of renal hypomagnesemia, see 602014. CLINICAL FEATURES Friedman et al. (1967) described convulsions in infants in the neonatal period. Primary hypomagnesemia, thought to be due to a defect in intestinal absorption, was present. Associated hypocalcemia was corrected by administration of magnesium alone. The genetic basis of the defect was suggested by its persistence over a period of months and by the fact that the parents were first cousins. Salet et al. (1970) reported the disorder in brother and sister. Manz et al. (1978) described 2 sisters with polyuria, hyposthenuria, hypomagnesemia, hypercalciuria, advanced nephrocalcinosis, low citrate excretion, and low glomerular filtration rates. Acid loading showed incomplete distal tubular acidosis. Hypomagnesium was due to renal magnesium wasting. Their hypothesis that the primary defect was one in renal tubular transport of magnesium was supported by the report by Passer (1976) of 2 adult patients with hypomagnesemia due to intestinal malabsorption combined with incomplete renal tubular acidosis. Both patients responded to Mg supplementation with correction of the renal acidification defect. Manz et al. (1978) suggested that the same disorder was present in the sibs reported by Michelis et al. (1972). Five pairs of affected sibs have been reported, including 2 instances of affected brother and sister (Evans et al., 1981). A parent (Paunier and Sizonenko, 1976) and a child (Freeman and Pearson, 1966) of a patient were said to be affected in other reports. Hennekam and Donckerwolcke (1983) observed Chinese brother and sister with primary hypomagnesemia. The 5-year-old sister, the proband, was admitted to hospital because of tetany following gastroenteritis for several days. She had never before had spasms. Intravenous calcium gluconate had no effect, but after magnesium chloride intravenously, the tetany stopped at once. The affected 17-year-old brother was discovered on family screening. He complained of muscle weakness for more than 2 years and had paresthesias of the fingers and spontaneous spasms. During venipuncture, Trousseau sign was elicited. In the sister and brother, serum magnesium was 0.56 and 0.49 nmol/l, respectively (normal, 0.7-1.0), and serum calcium was 2.09 and 2.31 nmol/l, respectively (normal, 2.25-2.75). The parents denied consanguinity. These authors found a total of 32 reported cases of primary hypomagnesemia of which 10 were in females. Although symptoms usually began in the first 3 months of life, they were delayed to the 36th year in the extreme. Consanguineous parents were reported by Becker et al. (1979) and by Friedman et al. (1967). Secondary magnesium-losing kidney can be caused by diuretics, gentamicin, mercury-containing laxatives, transplanted kidney, urinary tract obstruction, and the diuretic phase of acute renal failure. The disorder may be incorrectly diagnosed as primary hypoparathyroidism because of tetany and hypocalcemia, or as Bartter syndrome because of secondary renal potassium wasting. The diagnosis is made by finding hypomagnesemia with inappropriately high urinary magnesium excretion. Nephrocalcinosis is frequent. Chondrocalcinosis with arthritis is a recognized complication of magnesium depletion. Evans et al. (1981) reported 2 brothers, aged 39 and 29, with infertility and severe oligospermia but normal endocrine function. One of the brothers had sensorineural deafness. Neither deafness nor male infertility had been reported previously in this disorder. Dudin and Teebi (1987) described primary hypomagnesemia with secondary hypocalcemia as a cause of infantile tetany and convulsions in an Arab girl of consanguineous parentage. Praga et al. (1995) used the designation 'familial hypomagnesemia with hypercalciuria and nephrocalcinosis' and cited the patients reported by Michelis et al. (1972), Manz et al. (1978), Evans et al. (1981), Ulmann et al. (1985), and Rodriguez-Soriano et al. (1987) as examples of this disorder. They studied 8 patients from 5 different families. Mean age at diagnosis was 15 years with a range from 5 to 25. All 8 patients had polyuria-polydipsia; 5 had ocular abnormalities (corneal calcifications, chorioretinitis, nystagmus, myopia); 5 had recurrent urinary tract infections; and 2 had recurrent renal colic with passage of stones. Bilateral nephrocalcinosis was observed in all cases. The mean serum magnesium was 1.1 mg/dl with inappropriately high urinary magnesium excretions (70 mg/day). Hypercalciuria was present in every case except in those with advanced renal insufficiency. Serum parathormone levels were abnormally high. Serum Mg and urinary Ca became normal after renal transplantation in 5 patients. None of the 26 members of 4 of the affected families showed hypomagnesemia, renal insufficiency, or nephrocalcinosis; however, 11 (42%) had hypercalciuria and 4 of them presented with recurrent renal stones. Two family members had medullary sponge kidneys. In 1 family, 2 affected individuals were double first cousins. The daughters of 2 sisters married 2 brothers. In another family, the affected brother and sister in one sibship were cousins of an affected female in a first-cousin sibship. Praga et al. (1995) speculated that isolated hypercalciuria might be a heterozygous manifestation. Challa et al. (1994) described 2 female sibs with primary idiopathic hypomagnesemia, born to consanguineous parents. Both presented at 6 weeks of age, with convulsions and persistent hypocalcemia, which could not be controlled with anticonvulsants and/or calcium gluconate. Serum magnesium values of the mother and father were just below the normal range with normal serum calcium. Shalev et al. (1998) described the clinical presentation and long-term outcomes of 15 patients with autosomal recessive primary familial hypomagnesemia. The most common (67%) presenting events were generalized hypocalcemic-hypomagnesemic seizures at a mean age of 4.9 weeks. Thirteen infants who were treated soon after diagnosis with high-dose enteral magnesium developed normally. Their serum calcium returned to normal concentrations, but serum magnesium could not be maintained at normal concentrations. Delay in establishing a diagnosis led to a convulsive disorder with permanent neurologic impairment in 2 infants. Reported complications of prolonged hypomagnesemia such as renal stones, hypertension, arrhythmias, sudden death, or dyslipidemia were not observed. MAPPING Using whole genome scanning in 12 kindreds with typical recessive renal hypomagnesemia, Simon et al. (1999) demonstrated linkage to a segment of chromosome 3q with a lod score of 6.8. The trait was further localized to an approximately 1-cM interval flanked by loci 539-5 and D3S1288. MOLECULAR GENETICS By exon trapping, Simon et al. (1999) identified a gene at the chromosome 3q locus linked to recessive renal hypomagnesemia that they called paracellin-1 (603959). By SSCP and sequencing, they found 10 different mutations in 10 of the kindreds with primary hypomagnesemia. The mutations were found in homozygous state in 8 kindreds and in compound heterozygous state in 2 others. |
||||||
Transcript summary
Show transcripts |
|||||||
GeneRIFs |
|
||||||
Gene Ontology
localisation |
|||||||
biological process | |||||||
function | |||||||
entity | last update (YYYY-MM-DD) |
ClinVar | 2022-09-13 |
ClinVar (likely) pathogenic variants | 2024-04-09 |
Ensembl protein families | 2023-08-17 |
Entrez gene RIFS | 2024-04-09 |
Entrez gene history | 2024-04-09 |
Entrez gene positions | 2024-04-09 |
Entrez gene synonyms | 2024-04-09 |
Entrez genes | 2024-04-09 |
Gene Ontology | 2023-08-06 |
HPO | 2023-10-12 |
HPO / OMIM | 2023-10-12 |
HPO / Orphanet | 2023-10-12 |
HPO / genes | 2023-10-11 |
Interpro protein domains | 2023-08-17 |
MGD/OMIM | 2023-06-28 |
MGD/broad phenotypes | 2023-07-05 |
NCBI Entrez gene/Ensembl (Enseml Biomart) | 2024-04-09 |
NCBI Entrez gene/Ensembl (HGNC) | 2024-04-09 |
NCBI Entrez gene/Ensembl (MANE) | 2024-04-09 |
NCBI Entrez gene/Ensembl (NCBI gene2ensembl) | 2024-04-09 |
OMIM | 2023-08-02 |
Orphanet | 2023-08-23 |
Orphanet:HPO frequencies | 2023-08-23 |
Pfam | 2023-08-17 |
STRING (v12) | 2023-08-13 |
Swissprot/Uniprot IDs | 2023-08-17 |
gnomAD gene constraints | 2024-04-10 |